🎉 Pharmidex at Olink’s Lunchtime Networking Event! 🎉
February 4, 2025

We are delighted to announce that Martin Barrett, Head of Business Development at Pharmidex, will be attending the Lunchtime Networking Event – Olink PEA Technology Transforming Healthcare:

"The Impact of Proteogenomics" today, February 4, 2025, at Bee House, Milton, Abingdon, UK.


This event is a fantastic opportunity to explore how proteogenomics is shaping the future of healthcare and drug discovery. 

Martin looks forward to meeting fellow professionals, exchanging insights, and expanding Pharmidex’s network to support innovation in drug development.


📍 Event Details:

🗓 Date: February 4, 2025

📌 Location: Bee House, 140 Eastern Ave, Park Dr, Milton, Abingdon OX14 4SB


If you're attending, don’t hesitate to connect with Martin and discover how Pharmidex can help accelerate your drug discovery and development success!

#Pharmidex #Networking #Olink #Proteogenomics #DrugDiscovery #Innovation #Collaboration

Ian Knowles will be attending the Drug Delivery to the Lungs Conference

December 8, 2025
Head of Respiratory at Pharmidex , Ian Knowles will be attending the Drug Delivery to the Lungs Conference (DDL) on 10–12 December 2025 at the Edinburgh International Conference Centre. DDL brings together global leaders in pulmonary and respiratory drug delivery, and Ian looks forward to meeting fellow attendees, exploring collaborations, and discussing how Pharmidex can support and accelerate drug discovery and development across industry and academia. If you’ll be there too, feel free to reach out we look forward to building new connections and advancing innovation together.

Pharmidex at "Recent Clinical Candidates and SMR Award Meeting"

December 3, 2025
Pharmidex is pleased to announce that Dr. Mo Alavijeh (FRSC, FRSM) and Janette Dalay Robertson will attend the “Recent Clinical Candidates and SMR Award Meeting” this Thursday, 4 December 2025. If you’re attending, we’d be happy to connect!

Pharmidex will attend Genesis 2025 hosted by One Nucleus

December 2, 2025
Pharmidex is pleased to announce that Dr. Mo Alavijeh (FRSC, FRSM) , and our Dr. Ian Knowles , will attend Genesis 2025 this Wednesday, December 3rd, hosted by One Nucleus . They look forward to meeting fellow attendees, exploring new collaborations, and building partnerships with companies and academic groups to advance drug discovery and development. See you at Genesis 2025!
More Posts